论文部分内容阅读
本研究旨在进一步探讨通过消除下消化道念珠菌加阴道局部给药提高霉菌性外阴阴道炎疗效的可能性,同时确定阴道局部用克霉唑是否优于制霉菌素。 271例阴道和肠道均有念珠菌感染者,皆为阴道拭子标本用氢氧化钾法检查阳性,其中除11例外白色念珠菌也阳性。因7例失访,6例未按规定程序给药,故不列入本组分析。随机分三组,第一组83例,第二组86例,第三组89例。分别按以下顺序给予局部加口服联合治疗一周。口服:第一组制霉菌素、第二组安慰剂、第三组安慰剂;局部:第一组制霉菌素、第二组制霉菌素、第三组克霉唑。口
The purpose of this study was to further explore the possibility of improving the efficacy of fungal vulvovaginitis by topical administration of vaginal elimination of lower gastrointestinal candidiasis, and to determine whether vaginally superior clotrimazole is superior to nystatin. 271 cases of vaginal and intestinal Candida infection were vaginal swab specimens were positive with potassium hydroxide test, in addition to 11 cases of Candida albicans positive. Because of 7 cases lost to follow-up, 6 cases were not given the prescribed procedures, it is not included in this group analysis. Randomly divided into three groups, the first group of 83 cases, the second group of 86 cases, the third group of 89 cases. Respectively, according to the following order to give local plus oral combined treatment for a week. Oral: first nystatin, second placebo, third placebo; topical: first nystatin, second nystatin, third clotrimazole. mouth